Elon Musk's Neuralink may be testing its'Matrix' style computer-brain interfaces on animals, it has emerged. Devices being developed by the firm are designed to give people advanced mental abilities, which Musk says will let humanity keep up with future'god-like' AI systems. City planning documents submitted by the company reveal plans for'a small operating room for in vivo testing, and a small room to house rodents.' It is not known what the tests involved, whether they actually took place, or if they are on-going, as Neuralink has refused to comment on the matter. Elon Musk's (pictured) Neuralink may be testing its'Matrix' style computer-brain interfaces on animals, it has emerged.
Elon Musk's controversial startup to crate a'Matrix' interface to plug the human brain directly into a computer has raised over $27m, it has been revealed. Called Neuralink, SEC filings have revealed the scale of the firm for the first time. It has raised the $26.96 million of a technically still-open funding round that could grow to $100 million - although Musk took to Twitter to say the firm is no longer raising cash. Elon Musk's latest company Neuralink is working to link the human brain with a machine interface by creating micron-sized devices. Neuralink was registered in California as a'medical research' company last July, and he plans on funding the company mostly by himself.
Neuralink plans to test its brain machine interface technology with four of its N1 chips installed under patients' skin. Neuralink, Elon Musk's startup that's trying to directly link brains and computers, has developed a system to feed thousands of electrical probes into a brain and hopes to start testing the technology on humans in in 2020, Chief Executive Elon Musk revealed Tuesday. "A monkey has been able to control a computer with his brain," Musk said at a San Francisco livestreaming the presentation on YouTube Tuesday, revealing even more research results than the company's scientists expected. Neuralink's initial goal is to help people deal with brain and spinal cord injuries or congenital defects, Musk said. The technology could help paraplegics who have lost the ability to move or sense because of spinal cord injury -- a medical treatment that's a lot less shocking than radical sci-fi ideas like "consensual telepathy."
Interested in the future and want to experience even more?! eXplore More. Elon Musk's Neuralink, the secretive commercial company developing Brain Machine Interfaces (BMI) that one day they hope will connect human minds directly with AI's and machines, this week took the wrapper off the technology they've been developing. The company's goal, says Musk, is to eventually begin implanting devices in paralysed people so that they can control computers and smartphones with nothing more than their thoughts. And even though Musk gets a lot of the limelight in this area recently the US Military flexed their muscles and showed off their own version of Musk's technology that allowed paralysed volunteers to control fleets of F-35 fighter jets with just their thoughts, and elsewhere Mark Zuckerberg and his team are busy designing non-invasive BMI as part of his attempt to turn Facebook into the "world's first telepathic network." The first big advance Musk showed off was Neuralink's flexible bio-compatible "Threads," which are less likely to damage the brain than the materials used in many of today's traditional invasive BMI's.
Tesla founder Elon Musk has launched tech startup Neuralink to build implants that connect human brains with computer interfaces via artificial intelligence. The approaching technology would see groups of minuscule, flexible electrode "threads" implanted into the human brain by a neurosurgical robot. These threads detect and record the electrical signals in the brain, and transmit this information outside the body. This has the potential to create a scalable high-bandwidth brain-machine interface (BMI) system, meaning that it connects the brain to an external device to form a brain-machine interface. The goal is to use Neuralink to understand and treat different forms of brain or spine-related disorders.